Question Title

* 1. Name

Question Title

* 2. Email

Question Title

* 3. Following the session, which of the following classification systems will you use for staging your CLTI patients? (check all that apply)

Question Title

* 4. Following the session, how confident are you using the classification/staging systems?

Question Title

* 5. Following the session, would you practice shared decision-making with your CLTI patients in the development of their treatment plan? (Including patient-centered goals, discussion of all options).

Question Title

* 6. Following the session, will you routinely integrate the PLAN approach (patient risk, limb severity, anatomic complexity) with your CLTI patients in everyday practice?

Question Title

* 7. Following the session, during treatment of CLTI will you restage your patients if their symptoms have not resolved following an initial strategy?

Question Title

* 8. Following the session, will you discuss and offer both open and endo options for your CLTI patients who appear to be acceptable surgical candidates?

Question Title

* 9. Following the session, would you perform vein mapping in your CLTI patients who are acceptable surgical candidates, as part of a standard work up to outline their treatment options?

Question Title

* 10. Following the session, will you discuss prognosis based on presenting limb stage (WIfI) with your CLTI patients?

Question Title

* 11. Following the session, will you make decisions on urgency of revascularization based on WIfI staging?

Question Title

* 12. Following the session, will you make decisions on need for hospitalization based on WIfI staging?

Question Title

* 13. Following the session, in making recommendations about revascularization approach for your CLTI patients, will you:

Question Title

* 14. Following the session, would you incorporate a multidisciplinary team (i.e. routine involvement of specialist(s) from podiatry, cardiology, vascular medicine, radiology, others) in the care of your patients with CLTI?

Question Title

* 15. A 69 yo black female with type 2 diabetes presents with 2 weeks history of evolving gangrene of the left hallux to the level of the MTP joint, mild cellulitis, and rest pain. She has been generally active until very recently, no known CAD or CVD, stage 2 CKD. She takes metformin, atorvastatin, lisinopril, and aspirin. Femoral pulses are 2+ bilaterally; popliteal and pedal pulses not palpable. The left ABI is 0.5 and toe pressure measured at the second digit is 18 mm Hg with minimal pulsatility.

Based on the information provided, the most likely patient risk and limb stage severity for this patient is:

Question Title

* 16. A selective left leg angiogram is performed, revealing occlusion of the distal SFA at the adductor canal, diffuse and severe popliteal disease, occlusion of tibioperoneal trunk, reconstitution of the peroneal artery in the upper calf which then reconstitutes the distal anterior tibial in the lower third of the leg, with intact dorsalis pedis into the foot. The posterior tibial is not visualized. In using the GLASS system to estimate anatomic complexity of disease, which of the following are true:

Question Title

* 17. Following the session what practice changes do you intend to make as a result of this session?

T